Vertset Betahistine Dihydrochloride 24 mg Tablet 10 PIECES

IMPORTANT NOTICE (Rx): This product is classified as a Prescription-Only Medicine (Rx) in the Philippines. It is a targeted antivertigo inner ear microcirculation therapy that must strictly be purchased and taken under the direct clinical diagnosis, monitoring, and prescription of a licensed physician. Complete the full course of therapy as directed by your doctor.

Vertset Betahistine Dihydrochloride 24 mg Tablet (Targeted Inner Ear Microcirculation & Vertigo Maintenance Therapy — Sold per blister pack of 10 pieces) is an essential oral formulation prescribed for the management and relief of balance disorders, vertigo, and symptoms associated with Ménière's syndrome.

• Packaging & Quantity: Sold per blister pack of 10 pieces (1 sealed foil blister strip containing 10 tablets). Each tablet delivers 24 mg of active Betahistine (as dihydrochloride).

• Inner Ear Microvascular Vasodilation: Acts as a strong histamine $H_3$ receptor antagonist and weak $H_1$ agonist, promoting localized vasodilation and increased blood flow in the stria vascularis of the inner ear to reduce endolymphatic pressure.

Targeted Clinical Indications:

• Management of Ménière’s disease and vestibular vertigo characterized by true spinning sensations.

• Reduction of associated inner ear ringing, buzzing, or hissing sounds (tinnitus).

• Relief of ear fullness, pressure sensations, and secondary nausea/dizziness stemming from vestibular imbalance.

Directions for Use: Swallow the tablet with a full glass of water, preferably with or after meals to minimize mild stomach irritation:

• Standard Adult Maintenance Dose: 24 mg (1 tablet) twice daily (totaling 48 mg per day), or strictly as evaluated and prescribed by your physician.

• Consistency is key; improvements may be progressive and take several weeks to reach optimal therapeutic effect.

• Safety Precautions & Warnings: Contraindicated in patients with pheochromocytoma (a rare adrenal gland tumor). Use with caution in patients with a history of peptic ulcer disease or bronchial asthma. Avoid concurrent use with strong antihistamines, as they may reduce the therapeutic effect of betahistine. Discontinue use and consult your doctor if mild skin rashes, persistent headache, or dyspepsia occurs.

• Storage Guidance: Store at temperatures not exceeding 30°C in a dry place protected from excessive heat, moisture, and direct sunlight. Keep the blister pack intact until use and securely out of reach of children.

FDA Registration No.: DRP-11797